FDA Approved: GLYCOPYRROLATE — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves an original ANDA for a generic glycopyrrolate product from Nivagen Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease
• Sialorrhea

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)

Snippet

ORIG AP for GLYCOPYRROLATE (GLYCOPYRROLATE)